279 related articles for article (PubMed ID: 26681767)
1. Isorhapontigenin suppresses growth of patient-derived glioblastoma spheres through regulating miR-145/SOX2/cyclin D1 axis.
Xu Z; Zeng X; Xu J; Xu D; Li J; Jin H; Jiang G; Han X; Huang C
Neuro Oncol; 2016 Jun; 18(6):830-9. PubMed ID: 26681767
[TBL] [Abstract][Full Text] [Related]
2. Induction of miR-137 by Isorhapontigenin (ISO) Directly Targets Sp1 Protein Translation and Mediates Its Anticancer Activity Both In Vitro and In Vivo.
Zeng X; Xu Z; Gu J; Huang H; Gao G; Zhang X; Li J; Jin H; Jiang G; Sun H; Huang C
Mol Cancer Ther; 2016 Mar; 15(3):512-22. PubMed ID: 26832795
[TBL] [Abstract][Full Text] [Related]
3. Cyclin d1 downregulation contributes to anticancer effect of isorhapontigenin on human bladder cancer cells.
Fang Y; Cao Z; Hou Q; Ma C; Yao C; Li J; Wu XR; Huang C
Mol Cancer Ther; 2013 Aug; 12(8):1492-503. PubMed ID: 23723126
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional and post-transcriptional upregulation of p27 mediates growth inhibition of isorhapontigenin (ISO) on human bladder cancer cells.
Jiang G; Huang C; Li J; Huang H; Wang J; Li Y; Xie F; Jin H; Zhu J; Huang C
Carcinogenesis; 2018 Mar; 39(3):482-492. PubMed ID: 29409027
[TBL] [Abstract][Full Text] [Related]
5. Isorhapontigenin (ISO) inhibits stem cell-like properties and invasion of bladder cancer cell by attenuating CD44 expression.
Luo Y; Tian Z; Hua X; Huang M; Xu J; Li J; Huang H; Cohen M; Huang C
Cell Mol Life Sci; 2020 Jan; 77(2):351-363. PubMed ID: 31222373
[TBL] [Abstract][Full Text] [Related]
6. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-520b affects the proliferation of human glioblastoma cells by directly targeting cyclin D1.
Liu X; Wang F; Tian L; Wang T; Zhang W; Li B; Bai YA
Tumour Biol; 2016 Jun; 37(6):7921-8. PubMed ID: 26700671
[TBL] [Abstract][Full Text] [Related]
8. Isorhapontigenin (ISO) inhibited cell transformation by inducing G0/G1 phase arrest via increasing MKP-1 mRNA Stability.
Gao G; Chen L; Li J; Zhang D; Fang Y; Huang H; Chen X; Huang C
Oncotarget; 2014 May; 5(9):2664-77. PubMed ID: 24797581
[TBL] [Abstract][Full Text] [Related]
9. Isorhapontigenin inhibition of basal muscle-invasive bladder cancer attributed to its downregulation of SNHG1 and DNMT3b.
Meng H; Yang R; Lin Q; Du W; Chu Z; Cao Y; Du M; Zhao Y; Xu J; Yang Z; Xie X; He L; Huang C
BMC Cancer; 2024 Jun; 24(1):737. PubMed ID: 38879516
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-149 is epigenetically silenced tumor-suppressive microRNA, involved in cell proliferation and downregulation of AKT1 and cyclin D1 in human glioblastoma multiforme.
Ghasemi A; Fallah S; Ansari M
Biochem Cell Biol; 2016 Dec; 94(6):569-576. PubMed ID: 27783537
[TBL] [Abstract][Full Text] [Related]
11. Induction of RAC1 protein translation and MKK7/JNK-dependent autophagy through dicer/miR-145/SOX2/miR-365a axis contributes to isorhapontigenin (ISO) inhibition of human bladder cancer invasion.
Hua X; Xiang D; Guo M; Qian X; Chen R; Li T; Tian Z; Xu J; Huang C; Xie Q; Huang C
Cell Death Dis; 2022 Aug; 13(8):753. PubMed ID: 36045117
[TBL] [Abstract][Full Text] [Related]
12. A Sox2:miR-486-5p Axis Regulates Survival of GBM Cells by Inhibiting Tumor Suppressor Networks.
Lopez-Bertoni H; Kotchetkov IS; Mihelson N; Lal B; Rui Y; Ames H; Lugo-Fagundo M; Guerrero-Cazares H; Quiñones-Hinojosa A; Green JJ; Laterra J
Cancer Res; 2020 Apr; 80(8):1644-1655. PubMed ID: 32094299
[TBL] [Abstract][Full Text] [Related]
13. miR-340 inhibits glioblastoma cell proliferation by suppressing CDK6, cyclin-D1 and cyclin-D2.
Li X; Gong X; Chen J; Zhang J; Sun J; Guo M
Biochem Biophys Res Commun; 2015 May; 460(3):670-7. PubMed ID: 25817794
[TBL] [Abstract][Full Text] [Related]
14. MiR-429 suppresses glioblastoma multiforme by targeting SOX2.
Dong H; Hao X; Cui B; Guo M
Cell Biochem Funct; 2017 Jul; 35(5):260-268. PubMed ID: 28749077
[TBL] [Abstract][Full Text] [Related]
15. Sex determining region Y-box 2 inhibits the proliferation of colorectal adenocarcinoma cells through the mTOR signaling pathway.
Liu H; Du L; Wen Z; Yang Y; Li J; Dong Z; Zheng G; Wang L; Zhang X; Wang C
Int J Mol Med; 2013 Jul; 32(1):59-66. PubMed ID: 23599173
[TBL] [Abstract][Full Text] [Related]
16. miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.
Deng M; Zeng C; Lu X; He X; Zhang R; Qiu Q; Zheng G; Jia X; Liu H; He Z
Cancer Lett; 2017 Sep; 403():175-185. PubMed ID: 28634044
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus Immediate-Early Proteins Promote Stemness Properties in Glioblastoma.
Soroceanu L; Matlaf L; Khan S; Akhavan A; Singer E; Bezrookove V; Decker S; Ghanny S; Hadaczek P; Bengtsson H; Ohlfest J; Luciani-Torres MG; Harkins L; Perry A; Guo H; Soteropoulos P; Cobbs CS
Cancer Res; 2015 Aug; 75(15):3065-76. PubMed ID: 26239477
[TBL] [Abstract][Full Text] [Related]
18. MiR-454 inhibited cell proliferation of human glioblastoma cells by suppressing PDK1 expression.
Fang B; Zhu J; Wang Y; Geng F; Li G
Biomed Pharmacother; 2015 Oct; 75():148-52. PubMed ID: 26297548
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1.
Bier A; Giladi N; Kronfeld N; Lee HK; Cazacu S; Finniss S; Xiang C; Poisson L; deCarvalho AC; Slavin S; Jacoby E; Yalon M; Toren A; Mikkelsen T; Brodie C
Oncotarget; 2013 May; 4(5):665-76. PubMed ID: 23714687
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-202 induces cell cycle arrest and apoptosis in lung cancer cells through targeting cyclin D1.
Jiang J; Huang J; Wang XR; Quan YH
Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2278-84. PubMed ID: 27338052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
